| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |